Xenon Pharmaceuticals Inc. ($XENE)
Filing Information
| Accession Number | 0001193125-26-256120 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 4, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
17,390
Total Value
$0.00
P&L
+inf% (+$619,641.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Shares | โ | Jun 1, 2026 | Exercise/Conversion | 2,645 | โ | โ | 2,645 | Direct | โ | View Details | |
Director | Restricted Share Units | Derivative | Jun 1, 2026 | Exercise/Conversion | 2,645 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Share Option (Right to Buy) | Derivative | Jun 3, 2026 | Grant/Award | 10,507 | $0.00 | $0.00 | 10,507 | Direct | โ | View Details | |
Director | Restricted Share Units | Derivative | Jun 3, 2026 | Grant/Award | 1,593 | $0.00 | $0.00 | 1,593 | Direct | โ | View Details |